in

The diabetes monitoring devices market is projected to grow at an annualized rate of ~8%, till 2030

Roots Analysis has done a detailed study on “Diabetes Monitoring Devices Market, 2020-2030”, covering key aspects of the industry’s evolution and identifying potential future growth opportunities.

To order this 180+ page report, which features 60+ figures and 80+ tables, please visit this link

Key Market Insights 

  • Presently, over 240 novel, patient friendly diabetes monitoring devices are available / being developed by more than 80 device developers
  • The current market landscape features both established players and new entrants; more than 65% of the companies developing diabetes monitoring devices were established in the last two decades alone
  • A myriad of invasive and non-invasive diabetes monitoring solutions are available / under development, mostly intended for use by adult and geriatrics; the landscape also includes some wearable devices
  • With several glucose monitoring devices available in the market, developers are actively striving to differentiate proprietary offerings by incorporating various types of advanced and patient friendly features
  • Multiple deals have been inked in the past five years; a substantial number of agreements between stakeholders are focused on the integration of diabetes monitoring solutions with appropriate drug delivery devices
  • Several big pharmaceutical players are also actively expanding their capabilities in order to augment their respective product portfolios and comply to evolving industry benchmarks
  • Driven by the increasing diabetic patient population and the introduction of advanced / cost effective solutions, the diabetes monitoring devices market is poised to grow at a CAGR of 13%, till 2030

The projected market opportunity is anticipated to be well-distributed across different device components and key geographical regions

For more information, please visit https://www.rootsanalysis.com/reports/diabetes-monitoring-devices-market.html

Table of Contents

 

1.         PREFACE
1.1.       Scope of the Report
1.2.       Research Methodology
1.3.       Chapter Outlines

2.         EXECUTIVE SUMMARY

3.          INTRODUCTION

3.1.       Chapter Overview

3.2.       An Overview of Diabetes

3.2.1.    Classification of Diabetes

3.2.1.1. Type 1 Diabetes

3.2.1.2. Type 2 Diabetes

3.3.       Key Challenges Associated with Diabetes Monitoring

3.4.       Diabetes Monitoring Devices

3.4.1.    Devices for Self-Monitoring of Blood Glucose Levels

3.4.1.1. Blood Glucose Meter

3.4.1.2. Testing Strips

3.4.1.3. Lancets

3.4.2.    Continuous Blood Glucose Monitoring Devices

3.4.2.1. Sensors

3.4.2.2. Transmitters

3.4.2.3. Receivers

3.4.2.4. Patches

3.5.       Future Perspectives

4.          CURRENT MARKET LANDSCAPE

4.1.       Chapter Overview

4.2.       Diabetes Monitoring Devices: Overall Market Landscape

4.2.1.    Analysis by Type of Device

4.2.2.    Analysis by Current Status of Development

4.2.3.    Analysis by Target Patient Segment

4.2.4.    Analysis by Analyte Procurement

4.2.5     Analysis by Volume of Analyte Used

4.2.6.    Analysis by Processing Speed

4.2.7     Analysis by Wearability

4.2.8.    Analysis by Wireless Connectivity

4.2.9.    Analysis by Water Resistance Potential

4.2.10.  Analysis by Provisions for Alerts / Alarms

4.2.11.  Analysis by Device Memory Attributes

4.2.12.  Analysis by Glucose Measurement Range

 

4.3.       Diabetes Monitoring Devices: List of Developers

4.3.1.    Analysis by Type of Developer

4.3.2.    Analysis by Year of Establishment

4.3.3.    Analysis by Company Size

4.3.4.    Analysis by Geographical Location

4.3.5.    Leading Developers: Analysis by Number of Products

 

5.         PRODUCT COMPETITIVENESS ANALYSIS

5.1.       Chapter Overview

5.2.       Assumptions and Methodology

           5.2.1.    Product Competitiveness Analysis: Diabetes Monitoring Devices

5.2.1.1. Product Competitiveness Analysis: Continuous Blood Glucose Monitoring Devices

5.2.1.2. Product Competitiveness Analysis: Self-Monitoring Blood Glucose Devices

 

6.         PARTNERSHIPS AND COLLABORATIONS

6.1        Chapter Overview

6.2.       Partnership Models

6.3.       Diabetes Monitoring Devices: List of Partnerships and Collaborations

6.3.1.    Analysis by Year of Partnership

6.3.2.    Analysis by Type of Partnership

6.3.3.    Analysis by Year and Type of Partnership

6.3.4.    Analysis by Type of Device

6.3.5.    Most Active Players: Analysis by Number of Partnerships

6.3.6.    Geographical Analysis

6.3.6.1. Region-wise Distribution

6.3.6.2. Country-wise Distribution

 

7.         COMPANY PROFILES

7.1.       Chapter Overview

7.2.       ApexBio

7.2.1.    Company Overview

7.2.2.    Diabetes Monitoring Devices Portfolio

7.2.3.    Recent Developments and Future Outlook

7.3.       Ascensia Diabetes Care

7.3.1.    Company Overview

7.3.2.    Diabetes Monitoring Devices Portfolio

7.3.3.    Recent Developments and Future Outlook

7.4.       i-SENS

7.4.1.    Company Overview

7.4.2.    Diabetes Monitoring Devices Portfolio

7.4.3.    Recent Developments and Future Outlook

7.5.       Oak Tree Health

7.5.1.    Company Overview

7.5.2.    Diabetes Monitoring Devices Portfolio

7.5.3.    Recent Developments and Future Outlook

7.6        SD Biosensor

7.6.1.    Company Overview

7.6.2.    Diabetes Monitoring Devices Portfolio

7.6.3.    Recent Developments and Future Outlook

7.7.       TaiDoc Technology

7.7.1.    Company Overview

7.7.2.    Diabetes Monitoring Devices Portfolio

7.7.3.    Recent Developments and Future Outlook

7.8.       VivaCheck Laboratories

7.8.1     Company Overview

7.8.2.    Diabetes Monitoring Devices Portfolio

7.8.3.    Recent Developments and Future Outlook

 

8.         DIABETES MONITORING DEVICES RELATED INITIATIVES OF BIG PHARMA PLAYERS

8.1.       Chapter Overview

8.2.       Scope and Methodology

8.3.       Initiatives of Big Pharma Players

8.3.1.    Analysis by Type of Disease Management Solution

8.3.2.    Analysis by Number of Marketed and Clinical-Stage Diabetes Drugs

8.3.3.    Analysis by Diabetes Type

8.3.4.    Analysis by Type of Drug

8.3.5.    Analysis by Number of Partnerships

8.4.       Competitive Benchmarking of Big Pharma Players

8.4.1.    Spider Web Analysis: Company A

8.4.2.    Spider Web Analysis: Company B

8.4.3.    Spider Web Analysis: Company C

8.4.4.    Spider Web Analysis: Company D

 

9.         MARKET SIZING AND OPPORTUNITY ANALYSIS

9.1.       Chapter Overview

9.2.       Forecast Methodology and Assumptions

9.3.       Overall Diabetes Monitoring Devices Market, 2020-2030

9.4.       Diabetes Monitoring Devices Market, 2020-2030: Distribution by Type of Device

9.5.       Overall Self-Monitoring Blood Glucose Devices Market, 2020-2030

9.5.1.    Self-Monitoring Blood Glucose Devices Market, 2020-2030: Distribution by Diabetes Type

9.5.2.    Self-Monitoring Blood Glucose Devices Market, 2020-2030: Distribution by Device Component

9.5.3.    Self-Monitoring Blood Glucose Devices Market, 2020-2030: Geographical Distribution

9.5.3.1. Self-Monitoring Blood Glucose Devices Market in North America, 2020-2030

9.5.3.2. Self-Monitoring Blood Glucose Devices Market in Europe, 2020-2030

9.5.3.3. Self-Monitoring Blood Glucose Devices Market in Asia Pacific, 2020-2030

9.5.3.4. Self-Monitoring Blood Glucose Devices Market in Rest of the World, 2020-2030

9.6.       Overall Continuous Blood Glucose Monitoring Devices Market, 2020-2030

9.6.1.    Continuous Blood Glucose Monitoring Devices Market, 2020-2030: Distribution by Diabetes Type

             9.6.2.    Continuous Blood Glucose Monitoring Devices Market, 2020-2030: Distribution by Device Component

9.6.3.    Continuous Blood Glucose Monitoring Devices Market, 2020-2030: Geographical Distribution

9.6.3.1. Continuous Blood Glucose Monitoring Devices Market in North America, 2020-2030

9.6.3.2. Continuous Blood Glucose Monitoring Devices Market in Europe, 2020-2030

9.6.3.3. Continuous Blood Glucose Monitoring Devices Market in Asia Pacific, 2020-2030

9.6.3.4. Continuous Blood Glucose Monitoring Devices Market in Rest of the World, 2020-2030

 

10.        CONCLUDING REMARKS

10.1.     Chapter Overview

10.2.     Key Takeaways

 

11.        EXECUTIVE INSIGHTS

11.1.     Chapter Overview

11.2.     Cambridge Consultants

11.2.1.  Company Snapshot

11.2.2.  Interview Transcript: Ambuj Jain, General Manager- Business Development

 

11.3.     Know Labs

11.3.1.  Company Snapshot

11.3.2.  Interview Transcript: Ron Erickson, Founder and Chairman

 

12.        APPENDIX 1: TABULATED DATA

 

13.        APPENDIX 2: LIST OF COMPANIES AND ORGANIZATIONS

 

Contact Details

Gaurav Chaudhary

+1 (415) 800 3415

gaurav.chaudhary@rootsanalysis.com

This post was created with our nice and easy submission form. Create your post!

Leave a Reply

Your email address will not be published. Required fields are marked *

GIPHY App Key not set. Please check settings

What do you think?

The diabetes monitoring devices market is estimated to be worth USD 34 billion in 2030, predicts Roo

Cardano Is Hiring: Looking For Highly Motivated Blockchain Pros | CryptoGazette

The Cardano Foundation Addresses The Importance Of Blockchain | CryptoGazette